2Seventy Bio Inc (TSVT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | TSVT | AMGN | VRTX | REGN | GSK |
| Company | 2Seventy Bio Inc | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Gsk Plc ADR |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 4.05 | 306.92 | 484.41 | 1,005.19 | 41.69 |
| High | 4.19 | 310.01 | 484.87 | 1,016.00 | 42.00 |
| Low | 3.86 | 304.91 | 480.02 | 1,002.23 | 41.58 |
| Last | 4.00 | 309.23 | 479.78 | 1,004.72 | 41.79 |
| Change | -0.56 | +1.85 | -3.26 | -1.15 | -0.18 |
| % Change | -12.28% | +0.60% | -0.67% | -0.11% | -0.43% |
| Volume | 650,438 | 505,291 | 216,360 | 117,532 | 1,258,443 |
| 20-Day Average Volume | 484,084 | 2,292,999 | 1,148,893 | 373,567 | 4,280,953 |
| Previous Close | 4.56 | 307.38 | 483.04 | 1,005.87 | 41.97 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 4.45 | 308.77 | 448.20 | 982.35 | 44.23 |
| 20-Day Raw Stochastic | 13.65% | 54.22% | 96.86% | 84.62% | 23.73% |
| 20-Day Relative Strength | 42.64% | 58.83% | 74.97% | 63.74% | 43.62% |
| Weighted Alpha | -69.23 | +37.46 | +49.24 | +35.32 | +19.30 |
| Today's Opinion | 40% Sell | 88% Buy | 88% Buy | 88% Buy | 40% Buy |
| Previous Opinion | 8% Buy | 72% Buy | 88% Buy | 88% Buy | 40% Buy |
| Last Month's Opinion | 72% Buy | 40% Buy | 32% Buy | 72% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -7.81% since 05/30/24 | +2.84% since 05/30/24 | +8.93% since 05/30/24 | +3.74% since 05/30/24 | -5.05% since 05/30/24 |
| Low | 3.86 on 06/06/24 | 299.50 on 05/31/24 | 443.47 on 05/31/24 | 967.43 on 05/31/24 | 40.51 on 06/03/24 |
| High | 4.64 on 06/05/24 | 311.48 on 06/03/24 | 484.78 on 06/06/24 | 1,016.00 on 06/06/24 | 45.01 on 05/31/24 |
| 1-Month | |||||
| %Chg | -18.79% since 05/06/24 | +3.37% since 05/06/24 | +19.91% since 05/06/24 | +4.96% since 05/06/24 | -3.81% since 05/06/24 |
| Low | 3.86 on 06/06/24 | 295.49 on 05/30/24 | 394.03 on 05/07/24 | 952.14 on 05/08/24 | 40.51 on 06/03/24 |
| High | 5.10 on 05/07/24 | 321.44 on 05/15/24 | 484.78 on 06/06/24 | 1,016.00 on 06/06/24 | 45.92 on 05/15/24 |
| 3-Month | |||||
| %Chg | -29.11% since 03/06/24 | +11.92% since 03/06/24 | +17.18% since 03/06/24 | +3.51% since 03/06/24 | -1.94% since 03/06/24 |
| Low | 3.44 on 04/25/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 39.15 on 04/18/24 |
| High | 5.99 on 04/01/24 | 322.60 on 05/03/24 | 484.78 on 06/06/24 | 1,016.00 on 06/06/24 | 45.92 on 05/15/24 |
| 6-Month | |||||
| %Chg | +71.05% since 12/06/23 | +14.93% since 12/06/23 | +36.54% since 12/06/23 | +20.40% since 12/06/23 | +15.55% since 12/06/23 |
| Low | 2.29 on 12/07/23 | 260.68 on 04/19/24 | 348.46 on 12/08/23 | 831.19 on 12/07/23 | 35.81 on 12/07/23 |
| High | 6.40 on 02/20/24 | 329.72 on 02/05/24 | 484.78 on 06/06/24 | 1,016.00 on 06/06/24 | 45.92 on 05/15/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 234,407 | 164,889,392 | 124,649,928 | 110,832,784 | 86,980,312 |
| Shares Outstanding, K | 51,405 | 536,435 | 258,053 | 110,186 | 2,072,440 |
| Annual Sales | 100,390,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 37,725,000,000 |
| Annual Net Income | -217,570,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 6,129,940,000 |
| Last Quarter Sales | 12,440,000 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 9,337,020,000 |
| Last Quarter Net Income | -52,670,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | 1,326,430,000 |
| 60-Month Beta | 1.80 | 0.60 | 0.41 | 0.13 | 0.66 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.81 on 05/08/24 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | 1.09 on 05/01/24 |
| Latest Earnings Date | 05/08/24 | 05/02/24 | 05/06/24 | 05/02/24 | 07/24/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.369 on 05/16/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 05/16/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.50 | 31.54 | 26.77 | 10.24 |